This company has shut down. Entheon Biomedical is no longer operating — its last tracked round was a Post-IPO Equity in 2022.
Explore the Startup GraveyardEntheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.
Entheon Biomedical has raised $3.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2022.
Entheon Biomedical is headquartered in Coquitlam, Canada.
Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.
Entheon Biomedical is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Entheon Biomedical — Funding & Investors." VCBacked, April 5, 2022, https://www.vcbacked.co/company/entheon-biomedical. Accessed August 13, 2026.
VCBacked. (2022). Entheon Biomedical — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/entheon-biomedical
{{cite web |title=Entheon Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/entheon-biomedical |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated